Rajendra Memorial Research Institute of Medical Sciences   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Patna India (1963)

Organization Overview

First Clinical Trial
2003
NCT00216346
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Rajendra Memorial Research Insititute of Medical Sciences | Rajendra Memorial Research Institute of Medical Sciences | Rajendra Memorial Research Institute of Medical Sciences (ICMR)

Active Ingredients

Drugs in Phase 4 Trials (2)

amphotericin b (fungizone) (5 trials)

paromomycin (humatin) (3 trials)

Drugs in Phase 3 Trials (2)

deoxycholic acid (kybella) (1 trial)

miltefosine (impavido) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leishmaniasis (Phase 4)

Leishmaniasis, Visceral (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 4